Combining biomarkers for the assessment of prognosis in acute coronary syndrome: More is not always better
- PMID: 38419612
- PMCID: PMC10899729
- DOI: 10.1016/j.ijcha.2024.101346
Combining biomarkers for the assessment of prognosis in acute coronary syndrome: More is not always better
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Seropian I.M., Sonnino C., Van Tassell B.W., Biasucci L.M., Abbate A. Inflammatory markers in ST-elevation acute myocardial infarction. Eur. Heart J. Acute Cardiovasc. Care. 2016;5:382–395. - PubMed
-
- Suleiman M., Khatib R., Agmon Y., et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J. Am. Coll. Cardiol. 2006;47:962–968. - PubMed
-
- Makris K., Kafkas N. Neutrophil gelatinase-associated lipocalin in acute kidney injury. Adv. Clin. Chem. 2012;58:141–191. - PubMed
-
- Yndestad A., Landrø L., Ueland T., et al. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur. Heart J. 2009;30:1229–1236. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
